Here are relevant reports on : ai-voice-synthesis-market
-
AI SDR Market by Offering (Email Generators, Enrichment, AI Script, Template Generators, Meeting Booking), Use Case (Appointment Scheduling, Prospecting, Outreach, CRMs, Data Management, Follow up, Research, Sales Engagement) - Global Forecast to 2030
The AI SDR market is expanding rapidly, with a market size projected to rise from about USD 4.12 billion in 2025 to USD 15.01 billion by 2030, registering a CAGR of 29.5%. The major players in the AI SDR market include HubSpot (US), Salesforce (US), 11x AI (UK), Artisan AI (US), Luru (US), AiSDR (US), Lyzr AI (US), Floworks (US), Common Room (US), Salesforge (Estonia), and Qualified (US).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
AI in Mining Market by Offering (Software, Services), Mining Type (Surface, Underground), Deployment Mode (On-Premises, Cloud, Hybrid), Technology (Generative AI, Machine Learning, NLP), Application, Vertical, and Region - Global Forecast to 2032
The AI in mining market is expected to grow from USD 2.60 billion in 2025 to USD 9.93 billion by 2032, at a compound annual growth rate (CAGR) of 21.1%during the forecast period. The Key Players Caterpillar (US), Komatsu Ltd. (Japan), Sandvik AB (Sweden), Epiroc AB (Sweden), Hitachi Construction Machinery Co., Ltd. (Japan), Hexagon AB (Sweden), Rockwell Automation (US), Siemens (Germany), Trimble Inc. (US), and ABB (Switzerland).
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) Market by Offering (Infrastructure, Software, Services), Technology (ML, NLP, Generative AI), Business Function (Operations & Supply Chain, Finance & Accounting), Enterprise Application, and End User - Global Forecast to 2032
The market for artificial intelligence is slated to expand from USD 371.71 billion in 2025 to USD 2,407.02 billion by 2032, at a CAGR of 30.6% during the forecast period. The major players in the AI market include Google (US), Microsoft (US), IBM (US), Oracle (US), AWS (US), Intel (US), Salesforce (US), SAP (Germany), AMD (US), Qualcomm (US), Cisco (US), Meta (US), HPE (US), Siemens (Germany), NVIDIA (US), Baidu (China), SAS Institute (US), OpenAI (US), Huawei (China), Alibaba Cloud (China), Centific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), iMerit (US), Telus International (Canada), Innodata (US), Sama (US), C3 AI (US), HQE Systems (US), Appier (Taiwan), Adept (US), H20.AI (US), Spot AI (US), Anthropic (US), Cohere (Canada), Inbenta (US), Character.ai (US), DeepL (Germany), Inflection AI (US), Arrow AI (US), Observe.ai (US), Anyscale (US), AI21 Labs (Israel), Persado (US), Dialpad (US), Graphcore (UK), Shield AI (US), Gamaya (Switzerland), Arthur AI (US), ADA (Canada), Mostly AI (Austria), Metropolis Technologies (US), Cerebras (US), Jasper (US), Soundful (US), Writesonic (US), One AI (Israel), Synthesia (UK), Snorkel (US), Labelbox (US), Appen (US), and Cogito Tech (US).
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Asia Pacific Oligonucleotide Synthesis Market by Product {Drugs [ASO, siRNA], Synthesized Oligos [Product (Primers, Probes), Type (Custom, Predesigned)], Reagents, Equipment}, Application (Therapeutic, Research, Diagnostics) - Forecast to 2030
The Asia Pacific Oligonucleotide Synthesis market, valued at USD 1.76 billion in 2024, stood at USD 2.08 billion in 2025 and is projected to advance at a resilient CAGR of 18.5% from 2025 to 2030, culminating in a forecasted valuation of USD 4.88 billion by the end of the period. This expansion is driven by increasing demand from therapeutics, diagnostics, and research.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Hexamethylenediamine Market by Application (Nylon Synthesis, Curing Agents, Lubricants, Biocides, Coatings Intermediate, Adhesives), End-Use Industry (Automotive, Textile, Paints & Coatings, Petrochemical) and Region - Global Forecast to 2027
The global hexamethylenediamine market is projected to reach USD 11.6 billion by 2027, moving at a CAGR of 5.4% during the forecast period. The hexamethylenediamine market comprises major solution providers, BASF SE (Germany), Merck KGaA (Germany), TORAY INDUSTRIES, INC. (Japan), Evonik (Germany), and DuPont de Nemours, Inc.(US) among others. The study includes an in-depth competitive analysis of these key players in the hexamethylenediamine market, with their company profiles, and key market strategies.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028
The global veterinary API market, valued at US$8.0 billion in 2022, stood at US$8.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$11.9 billion by the end of the period. The veterinary active pharmaceutical ingredient (API) market is growing due to various factors, including the increased occurrence of transboundary and zoonotic diseases, a rise in the global animal population and pet ownership, and the implementation of improved disease control and prevention measures.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Metal Organic Frameworks Market by Type (Zinc-based, Copper-based, Iron-based, Aluminium-based, Chromium-based), Synthesis Method (Solvothermal/Hydrothermal, Microwave-assisted, Mechanochemical), and Region - Global forecast to 2030
The metal organic frameworks market is expected to grow from USD 0.51 billion in 2024 to USD 1.70 billion by 2030, at a CAGR of 22.1% during the forecast period. Prominent companies include Nanorh (US), Framergy, Inc. (US), novoMOF (Switzerland), BASF SE (Germany), Numat Technologies, Inc. (US), MOFapps (Norway), Nuada (UK), ProfMOF (Norway), ACSYNAM (Canada), Promethean Particles Ltd. (UK), ACMOFS (China), GS Alliance Co., Ltd. (Japan), Physical Sciences Inc. (US), Majd Onsor Fartak (Iran), SyncMOF Inc. (Japan), Immaterial Ltd. (UK), Atomis Inc. (Japan), CD Bioparticles (US), Nanowiz Tech (India), Kerone Engineering Solutions Ltd. (India), Nanoshel LLC (US), Jiangsu Xianfeng Nanomaterial Technology Co., Ltd. (China), Decarbontek, Inc. (US), Svante Technologies Inc. (Canada), Nanochemazone (India)and among others.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Whole Exome Sequencing Market by Product [Systems, Kits (Library Preparation, Target Enrichment)], Services (Sequencing), Technology (Sequencing by Synthesis), & by Application (Cancer, Monogenic disorders) - Global Forecast to 2018
This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership in the market in the coming years. Growth in the North American market is likely to be driven by factors such as the increasing use of exome sequencing in rare disease research, increased government funding, and large number of sequencing-related conferences and annual meetings hosted by the U.S.
- Published: August 2014
- Price: $ 4950
- TOC Available:
-
miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024
The miRNA sequencing and assays market is projected to reach USD 343 million by 2024, at a CAGR of 11.2%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing.Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), NEB (UK), and 5 others.
- Published: March 2019
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
